Clinical trial
Effectiveness of Naltrexone and Lofexidine in Treating Detoxified Heroin Addicts…
NCT00218530 · National Institute on Drug Abuse (NIDA), NIH · Completed
Key facts
| NCT number | NCT00218530 |
|---|---|
| Title | Effectiveness of Naltrexone and Lofexidine in Treating Detoxified Heroin Addicts - 1 |
| Official title | Naltrexone and Lofexidine in Detoxified Heroin Addicts |
| Lead sponsor | National Institute on Drug Abuse (NIDA), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Heroin Dependence |
| Intervention type | Drug |
| Interventions | Lofexidine |
| Enrollment | 0 |
| Start date | Mar 1, 2003 |
| Completion | Sep 1, 2004 |
| First posted | Sep 22, 2005 |
| Last update posted | Jan 12, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: